MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day losing streak as stocks reclaim some shine
- Oil rises 1%, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Appleās foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
MeiraGTx Holdings plc (MGTX) PT Raised to $40 at Chardan Capital Markets; 3rd Investment by J&J
February 27, 2019 11:45 AM ESTChardan Capital Markets analyst Gbola Amusa raised the price target on MeiraGTx Holdings plc (NASDAQ: MGTX) to $40.00 (from $30.00) while maintaining a Buy rating.
Amusa commented, "MeiraGTx (a Chardan Top Pick for 2019), after a recently-announced strategic collaboration on inherited retinal diseases (IRDs) with J&J's Janssen Pharmaceuticals ($100 mm upfront, $340 mm milestones, 20% untiered royalties), announced an $80 mm private placement, with... More

